2022
DOI: 10.1101/2022.04.13.22273839
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Expression quantitative trait methylation analysis elucidates gene regulatory effects of DNA methylation: The Framingham Heart Study

Abstract: Background. Expression quantitative trait methylation (eQTM) analysis identifies DNA CpG sites at which methylation is associated with gene expression and may reveal molecular mechanisms of disease. The present study describes an eQTM resource of CpG-transcript pairs. Methods. DNA methylation was measured in blood samples from 1,045 Framingham Heart Study (FHS) participants using the Illumina 450K BeadChip and in 1,070 FHS participants using the Illumina EPIC array. Blood gene expression data were collected f… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 36 publications
0
4
0
Order By: Relevance
“…A CpG site was in the promoter region if it was located 0-1500 bases upstream of a transcription start site. To identify CpGs associated with gene expression, we used results from expression quantitative trait methylation (eQTM) analysis performed using the 450k chip (101) and the EPIC (102) in the Framingham Heart Study (FHS). For each set of CpGs selected for a given biomarker, we compared whether the set of CpGs were more likely to be eQTMs than CpGs that were not selected by comparing the proportion of eQTMs in the two groups.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A CpG site was in the promoter region if it was located 0-1500 bases upstream of a transcription start site. To identify CpGs associated with gene expression, we used results from expression quantitative trait methylation (eQTM) analysis performed using the 450k chip (101) and the EPIC (102) in the Framingham Heart Study (FHS). For each set of CpGs selected for a given biomarker, we compared whether the set of CpGs were more likely to be eQTMs than CpGs that were not selected by comparing the proportion of eQTMs in the two groups.…”
Section: Methodsmentioning
confidence: 99%
“…After FDR correction, gene-set enrichment of GO Biological Processes (BP) terms and KEGG pathways were not observed for either set of CpGs when mapped to their proximal genes (FDR q<0.01). When utilizing eQTM data from Keshawarz et al (2023), CpGs selected for the aSES-BIO and cSES-BIO mapped to the expression of 230 and 66 genes, respectively, in cis or in trans. Additionally, CpGs selected for aSES-BIO were associated with the expression of genes enriched for 8 GO BP terms related to cell death, T cell differentiation and activation, cell migration, and cell-cell signaling (SI Appendix, Table S12 and Figure S3).…”
Section: Functional Characterization Of Biomarker Cpgs Cpg Sites Sele...mentioning
confidence: 99%
“…CpG sites that were significantly associated with vitamin C or E intake at a FDR ≤ 0.01 were used in expression quantitative trait methylation (eQTM) analysis within the FHS cohort to identify downstream effects of DNA methylation on gene expression. eQTM analysis in the FHS has used DNA methylation data and RNA sequencing data to quantify the association between DNA methylation and gene expression independent of age, sex, white blood cell count, blood cell fraction, platelet count, genetic principal components (PCs), and DNA methylation PCs [ 45 ]. We identified significant cis associations between CpG sites and gene transcripts (i.e., associations where the CpG site was within 1Mb of the transcription start site) at a p-value of 1.0 × 10 −7 [ 46 ].…”
Section: Methodsmentioning
confidence: 99%
“…In the FHS Offspring and Third-Generation cohorts, expression profiling for 17,873 genes/transcripts was conducted using the Affymetrix Human Exon 1.0 ST GeneChip, derived from whole blood mRNA (Joehanes et al, 2012). On the other hand, as part of the TOPMed program, RNA-seq was performed on whole blood in these FHS cohorts using the Illumina NovaSeq system profiling expression of over 40,000 transcripts (Keshawarz et al, 2023). In the meta analysis, we only included nonoverlapping participants between the microarray and RNAseq platforms.…”
Section: Applications To Cvd Traitsmentioning
confidence: 99%